ArticleHuman vaccines & immunotherapeutics2022

Vaccine-Related adverse events following AZD1222 (ChAdOx1-nCoV-19) Covid-19 vaccine in solid malignancy patients receiving cancer treatment, as compared to age-matched healthy controls.

Nussara Pakvisal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.